Correlation Ventures, a San Diego and Palo Alto, California-based venture capital firm, closed its second fund, at $187.8m.
According to a regulatory form filed with the SEC, 70 investors backed Correlation Ventures II, L.P.
The doc lists CFO Grace Chui-Miller and partner Anu Pathria as people related to the raise. The firm’s team also includes David Coats, Managing Director, Trevor Kienzle, Managing Director, Moiz Saifee, Principal, and Collin West, Principal.
After years building a complete database of venture capital financings, covering nearly all U.S. venture investments over the last 20 years, Correlation Ventures has started investing by leveraging predictive analytics to improve decision-making processes and invest across several industry segments, U.S. geographies and investment stages—from seed through late stage.
The fund’s portfolio includes Able, AirPR, AirXpanders, AlienVault, Annexon Biosciences, Apsalar, Arista MD, Bloomz, BlueVine Capital, Boombotix, BoomTrain, Bunchball, CareWell Urgent Care, Casper, Crossbar, Distil, Dropoff, Earnest, edo interactive, Enlibrium, Flex Pharma, Framehawk, Galera Therapeutics, Getaround, Gild, Good Eggs, Grokker, Gynesonics, InstaEDU, Intervene, Ioxus, Karmic Labs, Kwik, Lean Data, Lever, Lytro, Madefire, Manifest, Mirna Therapeutics, Mirror, mNectar, MOGL, Nihao Pay, numberFire, Personal Capital, Placemeter, Pley, PowerInbox, PowerVision, Proximal Data, Retrofit, RQx Pharmaceuticals, SAY Media, Soldsie, Spirox, Splice Machine, Stray Boots, Swell, SynthoRX, Telly, Toma Biosciences, Trumaker, Upstart, Urjanet, Viglink, Virsto Software, Visually, Whisk, and Zebit.